Status:
COMPLETED
Efficacy of Postoperative Pain Control Between Transarticular VS Periartiucular Multimodal Drug Infiltration in Total Hip Arthroplasty: Double-blinded Randomized Control Trial
Lead Sponsor:
Department of Medical Services Ministry of Public Health of Thailand
Conditions:
Pain, Post Operative
Arthroplasty Complications
Eligibility:
All Genders
45-60 years
Phase:
NA
Brief Summary
This research aim to improve postoperative outcome in total hip arthroplasty(THA) by using local mixture infiltration as bupivacaine + NSAID + epinephrine + tranxemic acid. In the present time these m...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patient who would go on cemented and cementless THA
- age 45-60 years of age
- voluntary decision exclusion criteria
- bilateral THA
- revision surgery
- history of pelvic and hip surgery previously
- allergy to medication in protocol
- CKD stage 4-5, chronic liver disease with Child Pugh B or C
- pregnancy
- history of hip injection
- U/D
- hypercoagulable state
- abnormal laboratory coagulation study as INR \> 1.4 or aPTT \> 1.4
- abnormal platelet function
- thrombocytopenia
- PE , DVT, ischemic stroke, CAD/ischemic heart disease
- use of anticoagulant or hormonal usage
- anesthesia by general anesthesia or additional nerve block
- can not understand PCA usage
- use postopertive wound drainage
Exclusion
Key Trial Info
Start Date :
April 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05325671
Start Date
April 5 2022
End Date
October 31 2023
Last Update
January 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rajavithi Hospital
Bangkok, Thailand